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Deep ear painRefractory otalgia or deep ear pain is a complex clinical problem that poses signiﬁcant challenges to the
physicians. Here we report a case of a 39 year old female who presented to us with deep right ear pain which
started following cholesteatoma excision 11 years ago. Since onset of right ear pain, she had multiple ear
surgeries including microvascular decompression and excision of right temporal bone before presentation.
Following neuropsychological assessment and excluding underlying depression/anxiety, she underwent
peripheral nerve ﬁeld stimulation (PFNS) trial. She had a successful PFNS trial and underwent permanent
implantation of PFNS and pulse generator. She had N50% reduction in her pain intensity on VAS and pain
medications. She required explantation due to superﬁcial infection; however she was satisﬁed with her
therapy and looking forward for reimplantation. We report the ﬁrst case of successful management of
refractory deep ear pain using PFNS with a review of pertinent literature.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Otalgia or deep ear pain is a complex clinical problem that poses
signiﬁcant challenges to the physicians in terms of both differential
diagnosis andmanagement. Neuralgic deep ear pain can be associated
with either glossopharyngeal neuralgia or nervus intermedius
(geniculate neuralgia) neuralgia as one of the symptoms [1,2].
According to the International Classiﬁcation of Headache Disorders
(2nd edition), presence of a trigger factor is mandatory to establish
the diagnosis of either glossopharyngeal or nervus intermedius
neuralgia [3]. However there are reports of neuralgic otalgia in the
absence of obvious trigger factors [4].
Both glossopharyngeal and geniculate neuralgias are rare disorders
with an incidence of 0.2%–1.3% and only 150 reported cases so far in the
literature respectively [1,2]. The common surgical options are either
microvascular decompression of the nerve at the nerve root entry zone
or sectioning of the nerve. However there remains a cohort of patients
who are not relieved of their pain following these surgical proce-
dures [5–7]. There has been a burgeoning interest in the utility of
peripheral nerve ﬁeld stimulation (PFNS) for complex cranio-facial pain
and other regional pain syndromes [8–10]. This modality has not yeton; VAS, visual analogue scale;
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B.V. This is an open access article ubeen explored in the management of patients with refractory otalgia.
Here we report the ﬁrst case of successful management of refractory
deep ear pain using PFS with a review of pertinent literature.
Case illustration
A39yearoldmarriedCaucasian femalepresented toour ofﬁcewitha
long history of right deep ear pain. Her right ear pain started following
cholesteatoma (benign lesion consisting of keratinizing squamous
epithelium and erodes the mastoid process of temporal bone and skull
base) excision and insertion of tube in her ear 11 years ago (Fig. 1 a & b).
Since then she had multiple right ear surgeries including meatoplasty,
revision canaloplasty, tympanoplasty, mastoidectomy, insertion of
multiple ear tubes. In addition, she underwent repair of her right
tympanic membrane, removal of bony spurs and excision of cholestea-
toma. She also underwent sectioning of her right vestibular nerve due to
persistent pain. She was diagnosed to have right glossopharyngeal
neuralgia and underwent microvascular decompression of right
glossopharyngeal nerve 4 years ago and the postoperative course was
complicated with CSF leak. This surgery was also met with unsatisfac-
tory results. A year later she underwent tympanoplasty without
ossicular chain reconstruction and ultimately had resection of her
right temporal bone 2 years prior to presentation due to persistent right
deep ear pain (Fig. 1 c & d). At presentation, her right ear pain was
constant, burning, throbbing and aching in nature, 9/10 on visual
analogue scale (VAS) [Visual analogue scale is a reliable non-verbal
measurement scale which is commonly used to assess pain and
disability [11,12]. Patients are asked to draw a vertical line on a 10 cmnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. (a & b) CT temporal bone and MRI with contrast images at the time of presentation to our hospital following mastoidectomy at another hospital. (c & d) CT temporal bone and
MRI with contrast images at the most recent follow up following right radical mastoidectomy and obliteration of external auditory canal.
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“worst imaginable pain.”] and was occasionally radiating to the lateral
aspect of lower jaw. There were no other symptoms associated with
pain. Cold breezewas the only identiﬁed aggravating factor and nothing
was able to relieve her pain. Her past medical history included Meniere
disease, pancreatitis, bronchitis and depression. She was taking opioids
(Methadone 10 mg/tab, 6 tabs/day and oxymorphone 10 mg/tab,Fig. 2. X-ray lateral (a) and anterior–posterior views (b) showing the placement of an octode
PFNS therapy. Note the right retromastoid craniotomy defect.1–2 tabs/3times/day), antidepressants (citalopram 20 mg/tab, 1.5 tabs/
day), diazepam (5 mg/tab, 1 tab/4 times/day) and anti-emetic medica-
tions (promethazine 5 mg/tab, 1 tab/4 times/daily) at presentation. On
neurological examination, higher mental functions were normal and
except for absence of hearing in right ear, the rest of the cranial nerves
was normal. Motor, sensory and cerebellar examination did not reveal
any abnormality.electrode (Medtronic, Inc., Minneapolis, MN) in the preauricular region during the trial
Fig. 3. X-ray lateral (a) and anterior–posterior views (b) showing the placement of two octode electrodes (Medtronic, Inc., Minneapolis, MN) in the preauricular and infraorbital
regions during the permanent PFNS therapy.
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other medical and surgical treatment modalities, Neuromodulation
options were considered to alleviate her pain. Following written,
informed and valid consent, she underwent trial implantation of right
preauricular peripheral nerve stimulator lead implantation (Fig. 2).
The trial was done with percutaneous leads placed in front of the ear
and attached to an external stimulator. She reported N50% pain relief
in lower part of right ear. Following a successful trial of 7 days, she
decided to pursue the permanent implantation with additional
coverage of the jaw. Subsequently, she underwent permanent
implantation of right preauricular and infra-orbital peripheral nerve
stimulators and right infraclavicular pulse generator. This was done
through a cervical incision with leads being placed subcutaneously in
the pre-auricular and infra-orbital region. She experienced N50% pain
relief with reduction in pain medications following implantation.
However she was not getting adequate coverage in the upper part of
her right ear and an addition preauricular lead was added and
infraclavicular lead was explanted (Figs. 3 & 4). Following this
implantation, she was extremely satisﬁed with the therapy (N50%
pain relief, 4/10 on VAS). Unfortunately 3 months later, due to poor
healing secondary to scars of multiple ear surgeries in this region, she
had superﬁcial infection at the site of loops of electrodes and requiredFig. 4. X-ray lateral (a) and anterior–posterior views (b) showing the placement of two oct
revision PFNS therapy.explantation. Following explantation, her right ear pain returned to
baseline and she is looking forward to reimplantation of her system
following clearance of superﬁcial infection.Discussion
The sensory innervation of ear is complex and involves the ﬁfth
(third division), seventh, ninth and tenth cranial nerves along with
the second and third divisions of upper cervical nerve roots [4,13]. The
nociceptive impulses from the inner aspect of the tympanic
membrane are mediated by glossopharyngeal and vagus nerves,
whereas the external portion of the tympanic membrane is mediated
by trigeminal (auriculotemporal branch of mandibular division) and
facial nerves [4,13]. Similarly, auditory canal is innervated by
auriculotemporal and facial nerves [4,13].
Peripheral nerve ﬁeld stimulation was ﬁrst described byWall and
Street in 1967 [14]. In 1999, Weiner and Reed published the success
of this technique in patients with occipital neuralgia which fostered
the wider acceptance of this therapy [15]. Currently, PFNS has been
explored for a variety of regional pain syndromes [8–10]. PFNS has
been reported to cause N50% alleviation of pain on visual analogueode electrodes (Medtronic, Inc., Minneapolis, MN) in the preauricular region following
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pain [16–20].
Indications and contraindications for PFNS
Patients with severe, chronic refractory neuropathic pain who
failed all other modalities of treatment such as pharmacotherapy,
trans-cutaneous nerve stimulation, trigger point injections, nerve
blocks, physical therapy, Botox or acupuncture are ideal candidates for
PFNS therapy [19]. The pain either should be limited in the anatomical
distribution of a nerve or should be covered with combination of
available electrodes. Complete absence of sensations in the area of
pain is a relative contraindication for this therapy. In patients with
severe allodynia, bracketing the area of pain can be useful. There
should not be underlying neuropsychological issues associated with
chronic pain [8,19]. Successful trial with N50% reduction in pain
intensity on VAS is mandatory prior to permanent implantation. Apart
from contraindications similar to other surgical procedures such as
bleeding disorders, immunosuppression, active infection; those
speciﬁc to PFNS include underlying psychological issues, drug seeking,
inadequate family support, medico-legal issues and patients requiring
frequent MRI [8,19].
Surgical techniques and programming parameters
Both trial and permanent placements of PFNS are usually
performed under general anesthesia as a day care procedure. An
ON-Q tunneler (I-Flow, Lake Forest, CA) is used for the placement of
four or eight contact leads [Quad, Octad, Quad Plus, or Quad Compact
(Medtronic, Inc., Minneapolis, MN)] in the region of previously
demarcated area of pain. During the trial implantation of electrodes,
the entry points are created using the Tuohy needle and ON-Q
tunneler is then used to implant electrodes in the designated area of
pain. The electrodes are placed in epifascial plane under ﬂuoroscopic
guidance. During permanent implantation, an incision is made
(supraauricular region and cervical region as in this report) to
implant the electrodes in the epifascial plane using an ON-Q tunneler
and to accommodate and secure the loops of electrodes in the
subcutaneous pocket at the incision site. These electrodes are then
tunneled and hooked to the generator placed in a subcutaneous
pocket in the infraclavicular region. Low rate (20–50 Hz), low pulse
width (60–250 ms) and low amplitude (1.5–2 V) have been shown to
be efﬁcacious during PFNS programming.
Mechanisms of action
Though the leads are placed subcutaneously in front of the ear the
dermatomal stimulation is the same as the external potion of ear canal
and tympanic membrane and comes from the mandibular branch of
trigeminal nerve. Field stimulation in trigeminal nerve distribution is
already shown to be effective in neuropathic face pain [19,20].
Guarded cathodes in preauricular leads could drive the stimulationdeeper in ear. Also cross-talk between a pre and post-auricular lead
can drive the stimulation coverage inside the ear. This was not
possible in our patient due to extensive post-auricular scarring. Most
likely explanation why peripheral stimulation provides pain relief is
possibly related to gate closure at periphery and pain matrix
modulation centrally [19,20].
Conclusion
Refractory deep ear pain is a complex clinical problem. PFNS can be a
useful last resortmodality in this cohort of patientswhohave exhausted
all other treatmentmodalities. However, randomized controlled studies
are required to establish the efﬁcacy of PFNS in patients with refractory
otalgia and provide hope to these difﬁcult patients.
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